Abstract:Purpose This study presents a novel and comprehensive framework for evaluating magnetic resonance guided radiotherapy (MRgRT) workflow by integrating the Failure Modes and Effects Analysis (FMEA) approach with Time‐Driven Activity‐Based Costing (TDABC). We assess the workflow for safety, quality, and economic implications, providing a holistic understanding of the MRgRT implementation. The aim is to offer valuable insights to healthcare practitioners and administrators, facilitating informed decision‐making regarding the 0.35T MRIdian MR‐Linac system's clinical workflow. Methods For FMEA, a multidisciplinary team followed the TG‐100 methodology to assess the MRgRT workflow's potential failure modes. Following the mitigation of primary failure modes and workflow optimization, a treatment process was established for TDABC analysis. The TDABC was applied to both MRgRT and computed tomography guided RT (CTgRT) for typical five‐fraction stereotactic body RT (SBRT) treatments, assessing total workflow and costs associated between the two treatment workflows. Results A total of 279 failure modes were identified, with 31 categorized as high‐risk, 55 as medium‐risk, and the rest as low‐risk. The top 20% risk priority numbers (RPN) were determined for each radiation oncology care team member. Total MRgRT and CTgRT costs were assessed. Implementing technological advancements, such as real‐time multi leaf collimator (MLC) tracking with volumetric modulated arc therapy (VMAT), auto‐segmentation, and increasing the Linac dose rate, led to significant cost savings for MRgRT. Conclusion In this study, we integrated FMEA with TDABC to comprehensively evaluate the workflow and the associated costs of MRgRT compared to conventional CTgRT for five‐fraction SBRT treatments. FMEA analysis identified critical failure modes, offering insights to enhance patient safety. TDABC analysis revealed that while MRgRT provides unique advantages, it may involve higher costs. Our findings underscore the importance of exploring cost‐effective strategies and key technological advancements to ensure the widespread adoption and financial sustainability of MRgRT in clinical practice.

Evaluation of failure modes and effect analysis for routine risk assessment of lung radiotherapy at a UK center

Failure Mode and Effects Analysis Application in External Beam Radiotherapy

Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery

Clinical effects of re-evaluating a lung SBRT failure mode and effects analysis in a radiotherapy department

Clinical implementation of failure modes and effects analysis for gynecological high-dose-rate brachytherapy

Multi‐phase failure modes and effects analysis for low dose bilateral whole lung irradiation of COVID‐19 positive patients requiring respiratory ventilation

FMECA Application to Intraoperative Electron Beam Radiotherapy Procedure As a Quality Method to Prevent and Reduce Patient's Risk in Conservative Surgery for Breast Cancer

Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability

FMECA Application in Tomotherapy: Comparison between Classic and Fuzzy Methodologies

Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison

Implementing failure mode and effect analysis to improve the safety of volumetric modulated arc therapy for total body irradiation.

Application of failure mode and effects analysis to validate a novel hybrid Linac QC program that integrates automated and conventional QC testing

Process failure mode and effects analysis for external beam radiotherapy: Introducing a literature-based template and a novel action priority

Application of failure mode and effects analysis to optimization of linac quality controls protocol

FMEA Based Risk Assessment of Component Failure Modes in Industrial Radiography

Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis

Optimization of treatment workflow for 0.35T MR‐Linac system

Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer

The use of failure modes and effects analysis (FMEA) to review a medication incident reporting system in a hospital

FMEA occurrence values for four failure modes occurring using look-up tables for dose calculations

Use of failure modes and effects analysis to mitigate potential risks prior to implementation of an intravenous compounding technology